
Profitability, historical returns, and peer comparisons.
According to MEI Pharma, Inc.’s latest financial reports and current stock price. The company's current ROE is -97.27%. This represents a change of 241.81% compared to the average of -28.46% of the last 4 quarters.
The mean historical ROE of MEI Pharma, Inc. over the last ten years is -69.69%. The current -97.27% ROE has changed 39.57% with respect to the historical average. Over the past ten years (40 quarters), MEIP's ROE was at its highest in in the September 2023 quarter at 69.29%. The ROE was at its lowest in in the March 2021 quarter at -56.99%.
Average
-69.69%
Median
-81.46%
Minimum
-170.94%
Maximum
53.84%
Discovering the peaks and valleys of MEI Pharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 81.51%
Maximum Annual ROE = 53.84%
Minimum Annual Increase = -1611.95%
Minimum Annual ROE = -170.94%
| Year | ROE | Change |
|---|---|---|
| 2026 | -170.94% | 81.51% |
| 2025 | -94.18% | -274.92% |
| 2024 | 53.84% | -141.64% |
| 2023 | -129.30% | 24.45% |
| 2022 | -103.89% | 24.39% |
| 2021 | -83.52% | 39.87% |
| 2020 | -59.71% | 70.17% |
| 2019 | -35.09% | -55.81% |
| 2018 | -79.41% | -1611.95% |
| 2017 | 5.25% | -110.49% |
The current ROE of MEI Pharma, Inc. (MEIP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-70.43%
5-year avg
-88.89%
10-year avg
-69.69%
MEI Pharma, Inc.’s ROE is greater than MetaVia Inc. (-209.67%), less than Traws Pharma, Inc. (353.43%), greater than Elevation Oncology, Inc. (-77.48%), greater than PHAXIAM Therapeutics S.A. (-95.68%), greater than Pieris Pharmaceuticals, Inc. (-47.84%), greater than Dominari Holdings Inc. (-82.76%), less than Kineta, Inc. (374.84%), less than Nymox Pharmaceutical Corporation (53.17%), greater than COSCIENS Biopharma Inc. (-48.52%), greater than LakeShore Biopharma Co., Ltd (-18.43%),
| Company | ROE | Market cap |
|---|---|---|
| -209.67% | $7.91M | |
| 353.43% | $4.60M | |
| -77.48% | $21.63M | |
| -95.68% | $19.86M | |
| -47.84% | $17.96M | |
| -82.76% | $41.34M | |
| 374.84% | $7.05M | |
| 53.17% | $2.10M | |
| -48.52% | $8.57M | |
| -18.43% | $25.84M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MEI Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MEI Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is MEI Pharma, Inc.'s ROE?
How is the ROE calculated for MEI Pharma, Inc. (MEIP)?
What is the highest ROE for MEI Pharma, Inc. (MEIP)?
What is the 3-year average ROE for MEI Pharma, Inc. (MEIP)?
What is the 5-year average ROE for MEI Pharma, Inc. (MEIP)?
How does the current ROE for MEI Pharma, Inc. (MEIP) compare to its historical average?